NICE recommends Novartis’ heart failure drug, Entresto
21 March 2016 | By Victoria White
The UK’s National Institute for Health and Care Excellence (NICE) has recommended Novartis’ heart failure drug, Entresto (sacubitrial/valsartan).
List view / Grid view
News
Positive top-line results from Phase III study of romosozumab in osteoporosis
21 March 2016 | By Victoria White
The study demonstrated a statistically significant increase in bone mineral density at the lumbar spine in men with osteoporosis treated with romosozumab...
Yusen Logistics builds Logistics Center to expand service in Mexico auto market
Yusen Logistics, a leading third-party logistics provider, announced the start of construction of a logistics center near Celaya, Mexico, to meet the growing demands of its domestic and international automotive customers.
Gastric cancer treatment development shifting to mAbs
17 March 2016 | By Victoria White
The dominance of small molecules in the gastric cancer treatment space could be about to give way to monoclonal antibodies, according to GBI Research...
Allergan files ANDA to the FDA for generic Abraxane
17 March 2016 | By Victoria White
Allergan believes it is a first applicant to file an ANDA for generic Abraxane and, should it be approved, may get 180 days of generic market exclusivity...
Sir Andrew Witty to retire as CEO of GSK
17 March 2016 | By Victoria White
GSK has announced that Sir Andrew Witty, CEO, has indicated to the Board his intention to retire from the company in early 2017...
GSK’s Advair Diskus achieves primary endpoint in LABA safety study
17 March 2016 | By Victoria White
The VESTRI study compared Advair Diskus to fluticasone propionate monotherapy in children aged 4 – 11 years who have asthma...
First patient dosed in Halozyme’s PEGPH20 pancreatic cancer trial
17 March 2016 | By Victoria White
The trial will study PEGPH20 in combination with nab-paclitaxel and gemcitabine in patients with tumours that accumulate high levels of hyaluronan...
Amgen wins drug patent case against Sanofi and Regeneron
17 March 2016 | By Victoria White
A jury has delivered a verdict in Amgen's favour in a trial on the validity of two Amgen patents that describe and claim monoclonal antibodies to PCSK9...
NICE says ‘no’ to talimogene laherparepvec in melanoma
16 March 2016 | By Victoria White
NICE says there is not enough evidence to be able to say whether talimogene laherparepvec is as effective as other drugs used to treat advanced melanoma...
Vaxon completes enrolment in Phase IIb trial of Vx-001 in NSCLC
16 March 2016 | By Victoria White
Vx-001 is a therapeutic cancer vaccine based on proprietary antigens known as optimised cryptic tumour peptides...
FDA advisory committee adopts a positive review of Abbott’s Absorb stent
16 March 2016 | By Victoria White
Absorb is a first-of-its-kind bioresorbable device for the treatment of coronary artery disease. It dissolves completely after 2 to 3 years...
Freedom to evolve with Tecan’s Freedom EVO® 75
15 March 2016 | By Tecan
Researchers at the Complutense University of Madrid are using directed evolution techniques to develop new enzymes for a variety of bioprocessing applications...
Quotient Clinical incorporates Japanese bridging into a Translational Pharmaceutics® program
15 March 2016 | By Quotient Clinical
Quotient Clinical has announced the completion of its first clinical program involving Japanese healthy volunteers...
Verona Pharma announces positive headline data from RPL554 trial
15 March 2016 | By Victoria White
The study met its primary objective, with nebulised RPL554 demonstrating a dose-dependent bronchodilator response in asthma patients...
